BSOF Parallel Master Fund L.P., 10% Owner at Praxis Precision Medicines, Inc. (PRAX), sold 400,000 shares at $17.50 ($7.0M) on 2021-10-06, disclosed to the SEC on 2021-10-08.
Open-market sale of $7.0M PRAX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.